The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis [Corrigendum]

This article refers to:

The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis

Rogliani P, Matera MG, Ora J, Cazzola M, Calzetta L. Int J Chron Obstruct Pulmon Dis. 2017;12:3469–3485.

Page 3481, right column, last paragraph, line 3, the text “(fromoterol and indacaterol)” should read “(formoterol and indacaterol)”.